These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 313498)

  • 21. [Treatment of degenerative rheumatic diseases. Therapy of painful irritation-conditions of the spine and of periarthrosis using a new combination preparation].
    Gerhold H
    Fortschr Med; 1974 Aug; 92(22):958-61. PubMed ID: 4547109
    [No Abstract]   [Full Text] [Related]  

  • 22. [Anti inflammatory efficiency of oxyphenbutazone in amigdalitis].
    Martínez Gallardo F
    Prensa Med Mex; 1979; 43(1-2):41-4. PubMed ID: 548961
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pharmacological properties and therapeutic effect of azapropazon in rheumatic diseases].
    Fiegel G
    Z Allgemeinmed; 1973 Apr; 49(12):592-4. PubMed ID: 4576254
    [No Abstract]   [Full Text] [Related]  

  • 24. [Diclofenac in the treatment of inflammatory and degenerative diseases of the locomotor system].
    Goch JH; Adamska-Dyniewska H
    Wiad Lek; 1977 Jul; 30(13):1011-5. PubMed ID: 331688
    [No Abstract]   [Full Text] [Related]  

  • 25. European experiences with tolmetin in the treatment of rheumatic diseases.
    Maibach E
    Curr Ther Res Clin Exp; 1976 Mar; 19(3):350-62. PubMed ID: 817865
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapeutic and clinicopharmacological observations with oxyphenbutazone (Tanderil) and other anti-inflammatory agents of the pyrazolone group].
    Schmid E; Heinkel K; Jansen W; Meythaler C; Schäffer S; Tauber O
    Med Welt; 1967 Jan; 4():227-31. PubMed ID: 5300116
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experiences in the therapeutic efficacy of a combined preparation for the treatment of joint disorders of degenerative and rheumatic type].
    Guerzoni PL
    Clin Ter; 1975 Apr; 73(2):113-25. PubMed ID: 767034
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of some non-steroid antirheumatic drugs on tetrazoliumreductase activity of leucocytes (author's transl)].
    Trnavský K; Rovenský J; Tauchmann M; Lokaj J
    Cas Lek Cesk; 1976 Jun; 115(24):728-30. PubMed ID: 1085196
    [No Abstract]   [Full Text] [Related]  

  • 29. [Local oxyphenbutazone therapy in blunt injuries and rheumatic diseases].
    Schirmböck J
    Z Allgemeinmed; 1972 May; 48(13):652-3. PubMed ID: 4537948
    [No Abstract]   [Full Text] [Related]  

  • 30. [Studies on the tolerance of Realin in rheumatic diseases].
    Grimm-Strang M; Kwoczek J
    Med Monatsschr; 1972 Apr; 26(4):180-2. PubMed ID: 4537547
    [No Abstract]   [Full Text] [Related]  

  • 31. [Use of oxyphenylbutazone in rheumatic diseases].
    Roimicher S; Azevedo MN; Pereira Filho O
    Rev Bras Med; 1968 Jul; 25(7):477-80. PubMed ID: 5308619
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical experience with an indomethacin-phenylbutazone combination in various rheumatic diseases].
    Hernández Peńa M
    Rev Esp Reum Enferm Osteoartic; 1973; 16(2):111-31. PubMed ID: 4541698
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparison of bumadizone-, phenylbutazone- and oxyphenbutazone-plasma levels after a single oral dose of phenylbutazone and of bumadizone, respectively (author's transl)].
    Spahn H; Mutschler E; Geissler HE; Faust-Tinnefeldt G
    Arzneimittelforschung; 1981; 31(3):499-503. PubMed ID: 6894380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical control of the therapeutic action of a decontracting, anti-rheumatic, analgesic drug combination for topical use, in comparison with oxyphenbutazone].
    Magnanini R; Mazzoni G; Musiani M; Orlandi V; D'Antonio C
    Clin Ter; 1982 Apr; 101(2):151-65. PubMed ID: 6980084
    [No Abstract]   [Full Text] [Related]  

  • 35. Therapy with irritren in rheumatic degenerative diseases.
    Georgescu C; Dumitrescu C; Dănău M; Spandonidis S; Costache G
    Med Interne; 1986; 24(2):147-51. PubMed ID: 3487823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Actol in the treatment of rheumatic diseases].
    Furmaniuk M; Zimmermann-Górska I
    Reumatologia; 1974; 12(1):91-4. PubMed ID: 4546222
    [No Abstract]   [Full Text] [Related]  

  • 37. [Tiaprofenic acid in rheumatic diseases].
    Kchir MM; Zouari R; Hila A
    Tunis Med; 1983; 61(1):11-2. PubMed ID: 6335613
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of degenerative and inflammatory joint diseases with or without a new synthetic substance (parsalmide). Controlled clinical trial].
    Napoli A; Alderuccio B; Nannetti A
    Clin Ter; 1977 Dec; 83(5):541-7. PubMed ID: 343972
    [No Abstract]   [Full Text] [Related]  

  • 39. [Analgesic activity of cinnoxicam. Findings of clinical sensimetry].
    Biasi G; Piazzini M; Fioravanti A; Francioni C; Marcolongo R
    Clin Ter; 1989 Dec; 131(5):315-9. PubMed ID: 2532585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical experiences in the treatment of rheumatic and non-rheumatic infectious diseases with an antiphlogistic agents].
    Rhein E; Wenig A
    Z Allgemeinmed; 1970 Oct; 46(29):1464-6. PubMed ID: 5312376
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.